BioTime, Inc. (BTX) financial statements (2021 and earlier)

Company profile

Business Address 2173 SALK AVENUE
CARLSBAD, CA 92008
State of Incorp. CA
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:42313138134229
Cash and cash equivalents3392437224229
Short-term investments9217    
Other undisclosed cash, cash equivalents, and short-term investments0(0)(0)1(10)  
Restricted cash and investments  0    
Receivables 2433111
Inventory, net of allowances, customer advances and progress billings     00
Inventory     00
Other undisclosed current assets23221242
Total current assets:44583643264732
Noncurrent Assets
Property, plant and equipment6866683
Long-term investments and receivables  22  5 
Long-term investments     5 
Due from related parties  22    
Intangible assets, net (including goodwill)585937103439
Goodwill1111     
Intangible assets, net (excluding goodwill)474837103439
Deposits noncurrent assets1111110
Restricted cash and investments  0    
Other noncurrent assets      0
Other undisclosed noncurrent assets  3311710000
Total noncurrent assets:6468651311174742
TOTAL ASSETS:1081251021731439575
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:7566797
Accounts payable3221232
Accrued liabilities2122353
Employee-related liabilities2222211
Other undisclosed accounts payable and accrued liabilities1000000
Deferred revenue00
Debt1100000
Deferred revenue and credits0100
Contract with customer, liability0
Other undisclosed current liabilities0  0130
Total current liabilities:86779127
Noncurrent Liabilities
Long-term debt and lease obligation340000 
Long-term debt, excluding current maturities   000 
Finance lease, liability00
Capital lease obligations000  
Operating lease, liability34
Liabilities, other than long-term debt2400015
Deferred revenue and credits0010
Deferred revenue 0
Deferred rent credit  0
Deferred tax liabilities, net    5
Deferred income tax liabilities23
Other liabilities    000
Other undisclosed noncurrent liabilities0022250
Total noncurrent liabilities:5832365
Total liabilities:131499121812
Stockholders' equity
Stockholders' equity attributable to parent96113941631182736
Preferred stock      4
Common stock394387354378318274235
Treasury stock, value    (3)(18)(20)
Additional paid in capital      0
Accumulated other comprehensive income (loss)(4)(1)10(1)(0)0
Accumulated deficit(294)(273)(262)(216)(196)(229)(182)
Stockholders' equity attributable to noncontrolling interest(1)(2)(2)2135026
Total stockholders' equity:95111921641317663
TOTAL LIABILITIES AND EQUITY:1081251021731439575

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues2453675
Revenue, net3675
Cost of revenue(0)(0)(0)(0)(0)(1)(1)
Gross profit:1353664
Operating expenses(28)(42)(46)(44)(65)(72)(55)
Other undisclosed operating income   2   
Operating loss:(26)(39)(42)(39)(59)(66)(51)
Nonoperating income (expense)520(5)16783(0)
Investment income, nonoperating    494 
Foreign currency transaction gain, before tax      0
Other nonoperating income (expense)33(1)1(0)(0)(0)
Interest and debt expense   (3)   
Income (loss) from continuing operations before equity method investments, income taxes:(22)(19)(47)(26)19(63)(51)
Other undisclosed income from continuing operations before income taxes   3   
Income (loss) from continuing operations before income taxes:(22)(19)(47)(23)19(63)(51)
Income tax expense (benefit)1(7)0  57
Income (loss) before gain (loss) on sale of properties:(21)(27)(47)(23)19(58)(44)
Other undisclosed net income 15     
Net income (loss):(21)(12)(47)(23)19(58)(44)
Net income attributable to noncontrolling interest0013  7
Other undisclosed net income attributable to parent    1511 
Net income (loss) attributable to parent:(21)(12)(46)(20)34(47)(36)
Preferred stock dividends and other adjustments     0(0)
Other undisclosed net loss available to common stockholders, basic     (1) 
Net income (loss) available to common stockholders, diluted:(21)(12)(46)(20)34(47)(36)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net income (loss):(21)(12)(47)(23)19(58)(44)
Other undisclosed comprehensive income (loss)(3)(2) 514117
Comprehensive income (loss):(24)(14)(47)(19)33(47)(36)
Comprehensive income (loss), net of tax, attributable to noncontrolling interest00(1)3(33)4844
Other undisclosed comprehensive income (loss), net of tax, attributable to parent  93(7)18(59)(51)
Comprehensive income (loss), net of tax, attributable to parent:(24)(14)45(22)18(59)(44)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: